Table 6.
CDEMS, % | Comparison Data, % | Source | |
---|---|---|---|
Diabetes Care Process | |||
Foot examination in past year | 52.8 | 74.1 | WA BRFSSb |
Eye examination in past year | 35.4 | 70.2 | WA BRFSS |
48.8 | Commercial HEDISc | ||
44.1 | Medicaid HEDISc | ||
64.2 | Medicare HEDISc | ||
58.0 | NHISd | ||
At least 1 HbA1c test in past year | 89.8 | 91.8 | WA BRFSS |
84.6 | Commercial HEDIS | ||
73.9 | Medicaid HEDIS | ||
87.3 | Medicare HEDIS | ||
At least 2 HbA1c tests in past year | 53.9 | 75.2 | WA BRFSS |
LDL cholesterol test in past yeare | 74.0 | 88.4 | Commercial HEDIS |
74.8 | Medicaid HEDIS | ||
90.6 | Medicare HEDIS | ||
Nephropathy screening in past year | 46.0 | 48.3 | Commercial HEDIS |
43.1 | Medicaid HEDIS | ||
52.6 | Medicare HEDIS | ||
Intermediate Health Outcome | |||
Last HbA1c test <7.0% | 51.6 | 37.0 | NHANESe |
Last HbA1c test <8.0% | 74.5 | Data unavailable | |
Last HbA1c test >9.0% | 13.2 | 31.9 | Commercial HEDIS |
49.5 | Medicaid HEDIS | ||
24.3 | Medicare HEDIS | ||
Last blood pressure reading <130/80 mm Hg | 34.0 | 35.8 | NHANES |
Last blood pressure reading <140/90 mm Hg | 67.3 | Data unavailable | |
Last LDL test <100 mg/dLf | 56.5 | 34.8 | Commercial HEDIS |
27.3 | Medicaid HEDIS | ||
41.2 | Medicare HEDIS | ||
Last LDL test <130 mg/dLg | 81.8 | 60.5 | Commercial HEDIS |
47.0 | Medicaid HEDIS | ||
66.9 | Medicare HEDIS |
Abbreviations: LDL, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1c.
Washington State Department of Health, 2004.
Washington State Behavioral Risk Factor Surveillance System, 2003-2005, Washington State Department of Health.
Healthcare Effectiveness Data and Information Set 2004, National Committee for Quality Assurance.
National Health Interview Survey (NHIS), 2003, National Center for Health Statistics.
National Health and Nutrition Examination Survey, 1999-2000, National Center for Health Statistics.
Includes patients with non-high density lipoprotein cholesterol (HDL) test (calculated by subtracting HDL from total cholesterol) in past year.
Includes patients with last non-HDL cholesterol test <160 mg/dL.